Olaris, Inc. to present novel data on two diagnostics in development for pediatric kidney and liver transplant recipients at the American Transplant Congress 2026 Meeting
Late-breaking research describes a non-invasive urine assay developed to distinguish multiple biopsy-confirmed kidney graft injury phenotypes in children, and an early plasma-based signature developed to identify liver transplant recipients at increased cardiovascular risk FRAMINGHAM,...
Late-breaking research describes a non-invasive urine assay developed to distinguish multiple biopsy-confirmed kidney graft injury phenotypes in children, and an early plasma-based signature developed to identify liver transplant recipients at increased cardiovascular risk FRAMINGHAM,...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.